日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PSMA/PET-guided stereotactic radiosurgery treatment for intracranial metastases from prostate cancer

PSMA/PET引导立体定向放射外科治疗前列腺癌颅内转移

Goulenko, Victor; Fekrmandi, Fatemeh; Madhugiri, Venkatesh Shankar; Almeida, Neil D; Lipinski, Lindsay; Fabiano, Andrew J; Snyder, Kenneth V; Chatta, Gurkamal; Guru, Kurshid A; Kuettel, Michael R; Fenstermaker, Robert A; Plunkett, Robert J; Prasad, Dheerendra

The temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggests a window-of-opportunity for checkpoint inhibitor therapy in prostate cancer

新辅助雄激素剥夺疗法后免疫反应的时间动态变化提示前列腺癌存在免疫检查点抑制剂治疗的“机会窗口”。

Jamroze, Anmbreen; Zhang, Renyuan; Ahuja, Kriti; Deng, Lei; Jatwani, Karan; Nguyen, Uyen; Farmer, Bailey; James, Gaybrielle; Mastri, Michalis; Eng, Kevin H; Xu, Bo; Saenger, Yvonne M; Yang, Yuanquan; Krolewski, John J; Tang, Dean G; Chatta, Gurkamal; Nastiuk, Kent L

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

辅助性帕博利珠单抗治疗与观察治疗肌层浸润性尿路上皮癌的比较

Apolo, Andrea B; Ballman, Karla V; Sonpavde, Guru; Berg, Stephanie; Kim, William Y; Parikh, Rahul; Teo, Min Yuen; Sweis, Randy F; Geynisman, Daniel M; Grivas, Petros; Chatta, Gurkamal; Reichert, Zachery Roger; Kim, Joseph W; Bilen, Mehmet Asim; McGregor, Bradley; Singh, Parminder; Tripathi, Abhishek; Cole, Suzanne; Simon, Nicholas; Niglio, Scot; Ley, Lisa; Cordes, Lisa; Srinivas, Sandy; Huang, Jiaoti; Odegaard, Meagan; Watt, Colleen; Petrylak, Daniel; Hoffman-Censits, Jeannie; Wen, Yujia; Hahn, Olwen; Mitchell, Cecilia; Tan, Alan; Streicher, Howard; Sharon, Elad; Moon, Helen; Woods, Michael; Halabi, Susan; Perez Burbano, Gabriela; Morris, Michael J; Rosenberg, Jonathan E

A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

一项评估阿特珠单抗联合或不联合人重组IL-7(CYT107)治疗晚期尿路上皮癌的II期开放标签、随机临床试验

Randy F Sweis,Gurkamal S Chatta,Rohit K Jain,Helen Moon,Scott Edward Delacroix,Alana Fang,Leonard D'Amico,Angela Shaulov Kask,Martin A Cheever,Steven Fling,Elad Sharon,Andreanne Lacroix,Judith C Kaiser,Russell K Pachynski,Evan Y Yu    0

A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

一项评估阿特珠单抗联合或不联合人重组IL-7(CYT107)治疗晚期尿路上皮癌的II期开放标签、随机临床试验

Randy F Sweis ,Gurkamal S Chatta ,Rohit K Jain ,Helen Moon ,Scott Edward Delacroix ,Alana Fang ,Leonard D'Amico ,Angela Shaulov Kask ,Martin A Cheever ,Steven Fling ,Elad Sharon ,Andreanne Lacroix ,Judith C Kaiser ,Russell K Pachynski ,Evan Y Yu

PSMA PET/CT for Detection of Metastatic Pancreatic Neuroendocrine Tumor

PSMA PET/CT 用于检测转移性胰腺神经内分泌肿瘤

Chatta, Rami; Tsai, Harrison Kwei; Pallod, Saurabh; Shah, Hina

Treatment of advanced urothelial cancer with nivolumab plus chemotherapy versus chemotherapy alone (CheckMate 901 study): a plain language summary

纳武利尤单抗联合化疗与单纯化疗治疗晚期尿路上皮癌的疗效比较(CheckMate 901 研究):简明扼要的总结

van der Heijden, Michiel S; Sonpavde, Guru; Powles, Thomas; Necchi, Andrea; Burotto, Mauricio; Schenker, Michael; Sade, Juan Pablo; Bamias, Aristotelis; Beuzeboc, Philippe; Bedke, Jens; Oldenburg, Jan; Chatta, Gurkamal; Ürün, Yüksel; Ye, Dingwei; He, Zhisong; Valderrama, Begoña P; Ku, Ja Hyeon; Tomita, Yoshihiko; Filian, Jeiry; Wang, Lily; Purcea, Daniela; Patel, Miraj Y; Nasroulah, Federico; Galsky, Matthew D

Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer

恩扎卢胺联合维奈托克治疗转移性去势抵抗性前列腺癌患者的Ib期研究

Perimbeti, Stuthi; Jamroze, Anmbreen; Gopalakrishnan, Dharmesh; Jain, Rohit; Jiang, Changchuan; Holleran, Julianne L; Parise, Robert A; Bies, Robert; Quinn, David; Attwood, Kristopher; Liu, Xiaozhuo; Green, Kelly; Kirk, Jason S; Beumer, Jan H; Tang, Dean G; Chatta, Gurkamal

Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient Survival

干细胞特性增强会促进前列腺癌的进展、可塑性、治疗耐药性和患者生存率降低。

Liu, Xiaozhuo; Cortes, Eduardo; Ji, Yibing; Zhao, Kathy; Ho, Julian; Liu, Yang Seagle; Davicioni, Elai; Feng, Felix Y; Alumkal, Joshi J; Spratt, Daniel E; Sweeney, Christopher J; Yu, Han; Hu, Qiang; Cheng, Zou; Zhang, Dingxiao; Chatta, Gurkamal; Nastiuk, Kent L; Goodrich, David W; Rycaj, Kiera; Jamroze, Anmbreen; Kirk, Jason S; Puzanov, Igor; Liu, Song; Wang, Jianmin; Tang, Dean G

Cell-resolved high-dimensional imaging analysis, therapeutic modeling, and a Phase Ib clinical study establish BCL-2 as a target across heterogeneous CRPC subtypes

细胞分辨高维成像分析、治疗模型构建以及 Ib 期临床研究证实 BCL-2 是异质性 CRPC 亚型的治疗靶点。

Jamroze, Anmbreen; Liu, Xiaozhuo; Hou, Surui; Li, Wen Jess; Yu, Han; Tracz, Amanda; Li, Qiuhui; Nastiuk, Kent; Chen, Xin; Huang, Jiaoti; Lin, Kevin; Lu, Yue; Puzanov, Igor; Kirk, Jason S; Chatta, Gurkamal; Tang, Dean G